LY 2157299 (CAS: 700874-72-2)
|
SKU-Pack Size | Availability | Size | Price | |
EBC51016-1ML | In Stock | 1mL(10mM in DMSO) | €102.70 | |
EBC51037-5MG | In Stock | 5mg | €89.70 | |
EBC51038-10MG | In Stock | 10mg | €128.70 | |
EBC51038-25MG | In Stock | 25mg | €258.70 | |
EBC51037-50MG | In Stock | 50mg | €388.70 |
Please Select The Country You Are In To Find Your Local Distributor. |
![]() |
OlaSciences | Phone£º+33 (0) 9 77 4001 556 |
87, rue des Suisses 65000 Nanterre, | E-mail£ºola@olasciences.com | |
France | France | Web£ºwww.olasciences.com |
Product Information | |||||||||||||||||||||
Synonym(s) | LY 2157299, LY-2157299, Galunisertib | ||||||||||||||||||||
Chemical Name | 4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide | ||||||||||||||||||||
Application | LY2157299 is a potent TGF ¦Â RI inhibitor | ||||||||||||||||||||
CAS Number | 700874-72-2 | ||||||||||||||||||||
Purity | ¡Ý98.0% | ||||||||||||||||||||
Molecular Weight | 369.42 | ||||||||||||||||||||
Molecular Formula | C₂₂H₁₉N₅O | ||||||||||||||||||||
SMILES | CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N | ||||||||||||||||||||
Target & IC50 | Flk-1: IC50 = 442 nM TGF¦Â RI: IC50 = 56 nM |
||||||||||||||||||||
Solubility | DMSO: 74 mg/mL (200.31 mM) | ||||||||||||||||||||
Preparing Stock Solutions |
|
||||||||||||||||||||
Shipping | Gel Pack | ||||||||||||||||||||
Storage | Store at -20¡ãC | ||||||||||||||||||||
Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |
Product Description | |
LY 2157299 is a potent inhibitor of Transforming Growth factor-Beta Receptor I (TGF-BetaR). TGF-Beta1 is involved in the control of cell growth, proliferation, differentiation, and apoptosis. LY2157299 is reported to disrupt Smad-2 phosphorylation in Human Umbilical Vein Endothelial Cells (HUVEC) and inhibit the growth and migration of tumor cells. |
Specific Protocols | |